lilly tirzepatide approval releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide approved for obesity by

Small errors in syringe handling translate directly into dosing errors that affect your results and side effect profile

Whats really amazing is the affordability of this medication with MDWatch

As more plaintiffs file lawsuits, Mounjaro has become a major focus in the ongoing Ozempic litigation MDL

People whose diabetes was recently diagnosed showed significant improvements in levels of HbA1c a measurement of blood sugar and their body weight

Las mujeres en el grupo de edad de 18 a 39 aos son el segmento con ms rpido crecimiento en el uso de los frmacos GLP-1 para perder peso, creciendo su consumo del 7% al 14% entre todas las consumidoras de estos frmacos entre el 2021 y el 2024